Press "Enter" to skip to content

Regulator directs drug manufacturers to incorporate new recorded adverse effects in leaflets

The Drug Controller General of India (DCGI) has written to all state drug regulators to direct manufacturers of certain antibiotics and anti-psychiatric drugs to include their new recorded adverse effects in the leaflets inside the package to promote patients’ safety.

Also Read:   U.S. appeals court signals sympathy to bid to strike down Obamacare